European project iPaCT awarded to Holger Grüll
Wednesday January 15 the kick-off meeting of the European Project “Image guided Pancreatic Cancer Therapy (iPaCT) took place in Eindhoven. IPaCT is a European Project co-coordinated by the Eindhoven University of Technology and Philips Research. It aims to establish a new kind of thermal therapy for pancreatic cancer.
Being usually diagnosed late stage and without any efficient therapy available, basically all patients die with an average life expectancy of only a few months after diagnosis. This creates a high clinical need for a better therapy.
Aim of this project is to develop a new combination treatment for pancreatic cancer using drug delivery from temperature sensitive nanocarriers, where high intensity focussed ultrasound is used for local heating of the pancreatic cancer tissue. This procedure is performed under image-guidance with MRI and ultrasound using an MRI scanner with and integrated ultrasound transducer.
Prof. Holger Grüll (chair: Molecular Imaging and Image guided Interventions/Biomedical NMR) receives for his participation 1.02 million euro subsidy, which contributes substantial funding for his research on MR-HIFU and drug delivery at the CIRE lab of the university.
The iPaCT consortium, consisting of two innovative SMEs (Imasonic and Neagen; responsible for critical technical innovations as the ultrasound transducer and imaging software), two hospitals (Universität München and University Medical Center Utrecht), the Eindhoven University of Technology and Philips Research as well as Philips Healthcare, represents the total chain from technology development, preclinical testing to clinical translation.